Literature DB >> 31037552

HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration.

Ivan Vujkovic-Cvijin1, Ma Somsouk2.   

Abstract

PURPOSE OF REVIEW: We discuss recent advances in understanding of gut bacterial microbiota composition in HIV-infected subjects and comment on controversies. We discuss the putative effects of microbiota shifts on systemic inflammation and HIV disease progression and potential mechanisms, as well as ongoing strategies being developed to modulate the gut microbiota in humans for amelioration of infectious and inflammatory diseases. RECENT
FINDINGS: Lifestyle and behavioral factors relevant to HIV infection studies have independent effects on the microbiota. Microbial metabolism of immunomodulatory compounds and direct immune stimulation by translocation of microbes are putative mechanisms contributing to HIV disease. Fecal microbiota transplantation, microbial enzyme inhibition, phage therapy, and rationally selected probiotic cocktails have emerged as promising strategies for microbiota modulation. Numerous surveys of the HIV gut microbiota matched for lifestyle factors suggest consistent shifts in gut microbiota composition among HIV-infected subjects. Evidence exists for a complex pathogenic role of the gut microbiota in HIV disease progression, warranting further study.

Entities:  

Keywords:  Engraftment; Fecal transplant; Gut microbiota; HIV; Inflammation

Mesh:

Year:  2019        PMID: 31037552      PMCID: PMC6579656          DOI: 10.1007/s11904-019-00441-w

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  114 in total

1.  Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.

Authors:  Noortje G Rossen; Susana Fuentes; Mirjam J van der Spek; Jan G Tijssen; Jorn H A Hartman; Ann Duflou; Mark Löwenberg; Gijs R van den Brink; Elisabeth M H Mathus-Vliegen; Willem M de Vos; Erwin G Zoetendal; Geert R D'Haens; Cyriel Y Ponsioen
Journal:  Gastroenterology       Date:  2015-03-30       Impact factor: 22.682

Review 2.  Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.

Authors:  Ethan Gough; Henna Shaikh; Amee R Manges
Journal:  Clin Infect Dis       Date:  2011-11       Impact factor: 9.079

Review 3.  Th17, gut, and HIV: therapeutic implications.

Authors:  Peter W Hunt
Journal:  Curr Opin HIV AIDS       Date:  2010-03       Impact factor: 4.283

4.  Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients.

Authors:  A Kök; L Hocqueloux; H Hocini; M Carrière; L Lefrou; A Guguin; P Tisserand; H Bonnabau; V Avettand-Fenoel; T Prazuck; S Katsahian; P Gaulard; R Thiébaut; Y Lévy; S Hüe
Journal:  Mucosal Immunol       Date:  2014-07-02       Impact factor: 7.313

5.  Gut epithelial barrier and systemic inflammation during chronic HIV infection.

Authors:  Ma Somsouk; Jacob D Estes; Claire Deleage; Richard M Dunham; Rebecca Albright; John M Inadomi; Jeffrey N Martin; Steven G Deeks; Joseph M McCune; Peter W Hunt
Journal:  AIDS       Date:  2015-01-02       Impact factor: 4.177

6.  Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.

Authors:  Cynthia L Monaco; David B Gootenberg; Guoyan Zhao; Scott A Handley; Musie S Ghebremichael; Efrem S Lim; Alex Lankowski; Megan T Baldridge; Craig B Wilen; Meaghan Flagg; Jason M Norman; Brian C Keller; Jesús Mario Luévano; David Wang; Yap Boum; Jeffrey N Martin; Peter W Hunt; David R Bangsberg; Mark J Siedner; Douglas S Kwon; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2016-03-09       Impact factor: 21.023

7.  Fecal microbiota therapy for recurrent Clostridium difficile infection in HIV-infected persons.

Authors:  Latesha Elopre; Martin Rodriguez
Journal:  Ann Intern Med       Date:  2013-05-21       Impact factor: 25.391

8.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection.

Authors:  Jason M Brenchley; David A Price; Timothy W Schacker; Tedi E Asher; Guido Silvestri; Srinivas Rao; Zachary Kazzaz; Ethan Bornstein; Olivier Lambotte; Daniel Altmann; Bruce R Blazar; Benigno Rodriguez; Leia Teixeira-Johnson; Alan Landay; Jeffrey N Martin; Frederick M Hecht; Louis J Picker; Michael M Lederman; Steven G Deeks; Daniel C Douek
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

9.  An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia.

Authors:  S M Dillon; E J Lee; C V Kotter; G L Austin; Z Dong; D K Hecht; S Gianella; B Siewe; D M Smith; A L Landay; C E Robertson; D N Frank; C C Wilson
Journal:  Mucosal Immunol       Date:  2014-01-08       Impact factor: 7.313

10.  Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Authors:  Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas I Paton; James D Neaton
Journal:  PLoS Med       Date:  2008-10-21       Impact factor: 11.069

View more
  33 in total

Review 1.  Immune Dysregulation in Myocardial Fibrosis, Steatosis, and Heart Failure: Current Insights from HIV and the General Population.

Authors:  Arjun Sinha; Matthew J Feinstein
Journal:  Curr HIV/AIDS Rep       Date:  2021-01-12       Impact factor: 5.071

2.  A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment.

Authors:  Scott Sherrill-Mix; Michelle Yang; Grace M Aldrovandi; Jason M Brenchley; Frederic D Bushman; Ronald G Collman; Satya Dandekar; Nichole R Klatt; Laurel A Lagenaur; Alan L Landay; Roger Paredes; Gilda Tachedjian; Jim A Turpin; Sergio Serrano-Villar; Catherine A Lozupone; Mimi Ghosh
Journal:  AIDS Res Hum Retroviruses       Date:  2022-01-25       Impact factor: 2.205

Review 3.  Through the Looking-Glass: Psychoneuroimmunology and the Microbiome-Gut-Brain Axis in the Modern Antiretroviral Therapy Era.

Authors:  Adam W Carrico; Emily M Cherenack; Leah H Rubin; Roger McIntosh; Delaram Ghanooni; Jennifer V Chavez; Nichole R Klatt; Robert H Paul
Journal:  Psychosom Med       Date:  2022-08-28       Impact factor: 3.864

4.  Blood-based inflammation biomarkers of neurocognitive impairment in people living with HIV.

Authors:  Naomi Swanta; Subhash Aryal; Vicki Nejtek; Sangeeta Shenoy; Anuja Ghorpade; Kathleen Borgmann
Journal:  J Neurovirol       Date:  2020-03-19       Impact factor: 2.643

5.  A Unique Gut Microbiome-Physical Function Axis Exists in Older People with HIV: An Exploratory Study.

Authors:  Stephanie M Dillon; Mona H Abdo; Melissa P Wilson; Jay Liu; Catherine M Jankowski; Charles E Robertson; Yunus Tuncil; Bruce Hamaker; Daniel N Frank; Samantha MaWhinney; Cara C Wilson; Kristine M Erlandson
Journal:  AIDS Res Hum Retroviruses       Date:  2021-04-30       Impact factor: 1.723

Review 6.  γδ T-cell responses during HIV infection and antiretroviral therapy.

Authors:  Jennifer A Juno; Emily M Eriksson
Journal:  Clin Transl Immunology       Date:  2019-07-17

7.  The Bacterium Akkermansia muciniphila: A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation.

Authors:  Jing Ouyang; John Lin; Stéphane Isnard; Brandon Fombuena; Xiaorong Peng; André Marette; Bertrand Routy; Meriem Messaoudene; Yaokai Chen; Jean-Pierre Routy
Journal:  Front Immunol       Date:  2020-04-09       Impact factor: 7.561

8.  Systems Analysis of Gut Microbiome Influence on Metabolic Disease in HIV-Positive and High-Risk Populations.

Authors:  Abigail J S Armstrong; Kevin Quinn; Jennifer Fouquier; Sam X Li; Jennifer M Schneider; Nichole M Nusbacher; Katrina A Doenges; Suzanne Fiorillo; Tyson J Marden; Janine Higgins; Nichole Reisdorph; Thomas B Campbell; Brent E Palmer; Catherine A Lozupone
Journal:  mSystems       Date:  2021-05-18       Impact factor: 6.496

9.  HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases.

Authors:  I Vujkovic-Cvijin; O Sortino; E Verheij; J Sklar; F W Wit; N A Kootstra; B Sellers; J M Brenchley; J Ananworanich; M Schim van der Loeff; Y Belkaid; P Reiss; I Sereti
Journal:  Nat Commun       Date:  2020-05-15       Impact factor: 14.919

Review 10.  Metformin effect on gut microbiota: insights for HIV-related inflammation.

Authors:  Jing Ouyang; Stéphane Isnard; John Lin; Brandon Fombuena; André Marette; Bertrand Routy; Yaokai Chen; Jean-Pierre Routy
Journal:  AIDS Res Ther       Date:  2020-03-10       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.